Health Care & Life Sciences » Pharmaceuticals | Biofermin Pharmaceutical Co. Ltd.

Biofermin Pharmaceutical Co. Ltd.

Biofermin Pharmaceutical Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY192.6
Market Cap
JPY27.43 B
Shares Outstanding
12.15 M
Public Float
3.84 M

Profile

Address
Sannomiya Central Building, 12/F
Kobe Hyogo 650
Japan
Employees -
Website http://www.biofermin.co.jp
Updated 07/08/2019
Biofermin Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products, quasi-drugs, veterinary drugs, agrichemicals, cosmetics, medical equipment, foods, beverages, food additives, feeds, feed additives and other chemicals. Its products include pharmaceutical items such as New Biofermin S, Biofermin Antidiarrheal, Biofermin, Stomachic Tablets, Biofermin VC, Biofermin Laxatives, Biofermin R, etc. It also provides various clinical test services.

Financials

View All

Hisataka Hotta
Chairman
Takaaki Fujimoto
President & Representative Director